21. A multicenter, single-blind, randomized, phase-2/3 study to evaluate immunogenicity and safety of a single intramuscular dose of biological E's Vi-capsular polysaccharide-CRM197 conjugate typhoid vaccine (TyphiBEVTM) in healthy infants, children, and adults in comparison with a licensed comparator. Issue 5 (30th November 2022) Authors: Thuluva, Subhash; Paradkar, Vikram; Matur, Ramesh; Turaga, Kishore; GV, Subba Reddy Journal: Human vaccines & immunotherapeutics Issue: Volume 18:Issue 5(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. A multicenter, single-blind, randomized, phase-2/3 study to evaluate immunogenicity and safety of a single intramuscular dose of biological E's Vi-capsular polysaccharide-CRM197 conjugate typhoid vaccine (TyphiBEVTM) in healthy infants, children, and adults in comparison with a licensed comparator. Issue 5 (30th November 2022) Authors: Thuluva, Subhash; Paradkar, Vikram; Matur, Ramesh; Turaga, Kishore; GV, Subba Reddy Journal: Human vaccines & immunotherapeutics Issue: Volume 18:Issue 5(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. A multicenter, single-blind, randomized, phase-2/3 study to evaluate immunogenicity and safety of a single intramuscular dose of biological E's Vi-capsular polysaccharide-CRM197 conjugate typhoid vaccine (TyphiBEVTM) in healthy infants, children, and adults in comparison with a licensed comparator. Issue 5 (30th November 2022) Authors: Thuluva, Subhash; Paradkar, Vikram; Matur, Ramesh; Turaga, Kishore; GV, Subba Reddy Journal: Human vaccines & immunotherapeutics Issue: Volume 18:Issue 5(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
24. A multicenter, single-blind, randomized, phase-2/3 study to evaluate immunogenicity and safety of a single intramuscular dose of biological E's Vi-capsular polysaccharide-CRM197 conjugate typhoid vaccine (TyphiBEVTM) in healthy infants, children, and adults in comparison with a licensed comparator. Issue 5 (30th November 2022) Authors: Thuluva, Subhash; Paradkar, Vikram; Matur, Ramesh; Turaga, Kishore; GV, Subba Reddy Journal: Human vaccines & immunotherapeutics Issue: Volume 18:Issue 5(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
25. A multicenter, single-blind, randomized, phase-2/3 study to evaluate immunogenicity and safety of a single intramuscular dose of biological E's Vi-capsular polysaccharide-CRM197 conjugate typhoid vaccine (TyphiBEVTM) in healthy infants, children, and adults in comparison with a licensed comparator. Issue 5 (30th November 2022) Authors: Thuluva, Subhash; Paradkar, Vikram; Matur, Ramesh; Turaga, Kishore; GV, Subba Reddy Journal: Human vaccines & immunotherapeutics Issue: Volume 18:Issue 5(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
26. A multicenter, single-blind, randomized, phase-2/3 study to evaluate immunogenicity and safety of a single intramuscular dose of biological E's Vi-capsular polysaccharide-CRM197 conjugate typhoid vaccine (TyphiBEVTM) in healthy infants, children, and adults in comparison with a licensed comparator. Issue 5 (30th November 2022) Authors: Thuluva, Subhash; Paradkar, Vikram; Matur, Ramesh; Turaga, Kishore; GV, Subba Reddy Journal: Human vaccines & immunotherapeutics Issue: Volume 18:Issue 5(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
27. A multicenter, single-blind, randomized, phase-2/3 study to evaluate immunogenicity and safety of a single intramuscular dose of biological E's Vi-capsular polysaccharide-CRM197 conjugate typhoid vaccine (TyphiBEVTM) in healthy infants, children, and adults in comparison with a licensed comparator. Issue 5 (30th November 2022) Authors: Thuluva, Subhash; Paradkar, Vikram; Matur, Ramesh; Turaga, Kishore; GV, Subba Reddy Journal: Human vaccines & immunotherapeutics Issue: Volume 18:Issue 5(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
28. A multicenter, single-blind, randomized, phase-2/3 study to evaluate immunogenicity and safety of a single intramuscular dose of biological E’s Vi-capsular polysaccharide-CRM197 conjugate typhoid vaccine (TyphiBEVTM) in healthy infants, children, and adults in comparison with a licensed comparator. Issue 5 (30th November 2022) Authors: Thuluva, Subhash; Paradkar, Vikram; Matur, Ramesh; Turaga, Kishore; GV, Subba Reddy Journal: Human vaccines & immunotherapeutics Issue: Volume 18:Issue 5(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
29. Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern. Issue 26 (9th June 2022) Authors: Pollet, Jeroen; Strych, Ulrich; Chen, Wen-Hsiang; Versteeg, Leroy; Keegan, Brian; Zhan, Bin; Wei, Junfei; Liu, Zhuyun; Lee, Jungsoon; Kundu, Rahki; Adhikari, Rakesh; Poveda, Cristina; Jose Villar, Maria; Rani Thimmiraju, Syamala; Lopez, Brianna; Gillespie, Portia M.; Ronca, Shannon; Kimata, Jason... Journal: Vaccine Issue: Volume 40:Issue 26(2022) Page Start: 3655 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗